WORLD’S FIRST CONTACTLESS SLEEP APNEA SOLUTION



Our Representatives

Yosi Azulay

Founder & CEO, Appscent Medical

Founder & CEO

Appscent Medical

Appscent Ltd. founded in 2017 and is a privately-held Israeli company • Our Mission is to offer personalized, home-based monitoring and therapy medical grade platform. • Proprietary te...

Company's Solutions

INNOVATIVE PATENTED TECHNOLOGY

Appscent Medical's Scentific™ device is a high-impact, zero-contact, sleep apnea relief solution designed to transform hundreds of millions of people’s night-time breathing patterns and overall health - forever revolutionizing the global sleep apnea devices market.

The Scentific™ device is indicated for reducing sleep apnea events among adult patients by monitoring patient respirations and scents dispersion when an apnea episode is detected.

Our disruptive innovation is a non-invasive, integrated system that includes a detection and therapeutic platform.

The detection platform is based on remote sensing technology integrated with AI, local, and cloud-based back end.

The non-contact sensors capture a range of physiological parameters which are then analyzed by our advanced AI algorithms that command the remedy platform to act based on a personalized physiological profile of the user.

Appscent’s breakthrough Scentific medical device offers contactless instant detection and immediate relief for sleep apnea.

The AI diagnostic platform monitors the patient’s actual breathing and sleep pattern.

Patented scent technology ensures a personalized odorant solution that reduces apnea events and duration.

Non-contact, non-invasive, effortless, and pleasant bedside solution.

Comfortable and easy handling, simple care, and low maintenance.

Prominent Case Study

Scentific™ is an academic spinoff developed from the results of many years of sleep research at Israel’s Weizmann Institute of Science.

A recent clinical study showed favorable results supporting a Scentific™ significantly reduced AHI (p = 0.02, BF10 = 115.85), reflecting an average decrease of 31.3% in the number of events.

Scentific™ also shifts the OSA severeness category shifting significantly.